Promore Pharma Overview
- Year Founded
-
2002
- Status
-
Acquired/Merged
- Employees
-
3
- Latest Deal Type
-
M&A
Promore Pharma General Information
Description
PMD Device Solutions AB develops and sells medical products for respiratory monitoring in both the hospital and homecare setting. Its primary product is RespiraSense, a solution used for monitoring respiratory rate to detect deterioration of a patient's general condition early and to avoid preventable respiratory failure and adverse patient outcomes. RespiraSense is, to the Company's knowledge, the world's only continuous, motion-tolerant respiratory rate monitor delivering class-leading reliability in measuring respiratory rate. RespiraSense is a novel technology that is commercialised in Europe, the UK, and FDA-cleared in the US.
Contact Information
Website
www.promorepharma.comCorporate Office
- Fogdevreten 2
- 171 65 Solna
- Sweden
Corporate Office
- Fogdevreten 2
- 171 65 Solna
- Sweden
Promore Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 29-Dec-2023 | Completed | Generating Revenue | |||
| 6. Bankruptcy: Liquidation | 29-Nov-2023 | Cancelled | Generating Revenue | |||
| 5. IPO | 06-Jul-2017 | Completed | Generating Revenue | |||
| 4. Early Stage VC | Completed | Generating Revenue | ||||
| 3. Corporate | 07-Jul-2016 | Completed | Generating Revenue | |||
| 2. Angel (individual) | 01-Jan-2016 | $1.71M | $1.72M | Completed | Startup | |
| 1. Accelerator/Incubator | $5.74K | $5.74K | Completed | Startup |
Promore Pharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary |
Promore Pharma Patents
Promore Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20180325807-A1 | Method and apparatus for applying a pharmaceutical agent to reduce post-surgical adhesions | Inactive | 11-May-2017 | ||
| CA-2825246-A1 | Human lactoferrin based peptides having anti-inflammatory activity | Inactive | 26-Jan-2011 | ||
| AU-2012210564-A1 | Human lactoferrin based peptides having antiinflammatory activity | Active | 26-Jan-2011 | ||
| AU-2012210564-B2 | Human lactoferrin based peptides having antiinflammatory activity | Inactive | 26-Jan-2011 | ||
| EP-2668204-A2 | Human lactoferrin based peptides having antiinflammatory activity | Active | 26-Jan-2011 | A61K38/10 |
Promore Pharma Signals
Promore Pharma Former Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Chalmers Ventures | Venture Capital | Minority | ||
| Granitor | Venture Capital | Minority | ||
| KDventures | Venture Capital | Minority | ||
| PharmaResearch (Pharmaceuticals) | Corporation | Minority | ||
| Rosetta Capital (UK) | Venture Capital | Minority |
Promore Pharma Acquisitions (2)
Promore Pharma’s most recent deal was a Reverse Merger with PMD Device Solutions for . The deal was made on 29-Dec-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| PMD Device Solutions | 29-Dec-2023 | Reverse Merger | Monitoring Equipment | ||
| Pharmasurgics | 01-Nov-2010 | Merger/Acquisition | Medical Supplies |
Promore Pharma Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Pergasus | Oxie, Sweden | 2021 |
Promore Pharma FAQs
-
When was Promore Pharma founded?
Promore Pharma was founded in 2002.
-
Where is Promore Pharma headquartered?
Promore Pharma is headquartered in Solna, Sweden.
-
What is the size of Promore Pharma?
Promore Pharma has 3 total employees.
-
What industry is Promore Pharma in?
Promore Pharma’s primary industry is Drug Discovery.
-
Is Promore Pharma a private or public company?
Promore Pharma is a Private company.
-
What is Promore Pharma’s current revenue?
The current revenue for Promore Pharma is .
-
How much funding has Promore Pharma raised over time?
Promore Pharma has raised $14M.
-
Who are Promore Pharma’s investors?
Chalmers Ventures, Granitor, KDventures, PharmaResearch (Pharmaceuticals), and Rosetta Capital (UK) are 5 of 6 investors who have invested in Promore Pharma.
-
When was Promore Pharma acquired?
Promore Pharma was acquired on 29-Dec-2023.
-
Who acquired Promore Pharma?
Promore Pharma was acquired by PMD Device Solutions.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process